Antithymocyte Globulin for Treatment of the Bone Marrow Failure Associated with Myelodysplastic Syndromes

Figure 2. Five-year probability of remaining progression free was 90% (95% CI, 80% to 100%). Dotted lines represent the upper and lower boundaries of confidence intervals. Covariate-adjusted time to progression for responders and nonresponders. Response status was ascertained at 8 months after treatment with antithymocyte globulin.
Figure 2. Five-year probability of remaining progression free was 90% (95% CI, 80% to 100%). Dotted lines represent the upper and lower boundaries of confidence intervals. Covariate-adjusted time to progression for responders and nonresponders. Response status was ascertained at 8 months after treatment with antithymocyte globulin. Overall time to progression (to refractory anemia with excess blast cells in transformation or to acute myelogenous leukemia) for the 61 patients enrolled in the study.Top.Bottom.

This Article

  1. Ann Intern Med August 6, 2002 vol. 137 no. 3 156-163
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. December 15, 2009, 151 (12)
  1. Alert me to current issues